Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Model-Based Spectral Library Approach for Bacterial Identification via Membrane Glycolipids.

Ryu SY, Wendt GA, Chandler CE, Ernst RK, Goodlett DR.

Anal Chem. 2019 Aug 15. doi: 10.1021/acs.analchem.9b03340. [Epub ahead of print]

PMID:
31369253
2.

Small Molecule Potentiation of Gram-Positive Selective Antibiotics against Acinetobacter baumannii.

Martin SE, Melander RJ, Brackett CM, Scott AJ, Chandler CE, Nguyen CM, Minrovic BM, Harrill SE, Ernst RK, Manoil C, Melander C.

ACS Infect Dis. 2019 Jul 12;5(7):1223-1230. doi: 10.1021/acsinfecdis.9b00067. Epub 2019 Apr 26.

PMID:
31002491
3.

Bacterial medium-chain 3-hydroxy fatty acid metabolites trigger immunity in Arabidopsis plants.

Kutschera A, Dawid C, Gisch N, Schmid C, Raasch L, Gerster T, Schäffer M, Smakowska-Luzan E, Belkhadir Y, Vlot AC, Chandler CE, Schellenberger R, Schwudke D, Ernst RK, Dorey S, Hückelhoven R, Hofmann T, Ranf S.

Science. 2019 Apr 12;364(6436):178-181. doi: 10.1126/science.aau1279.

PMID:
30975887
4.

Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.

Barker WT, Chandler CE, Melander RJ, Ernst RK, Melander C.

Bioorg Med Chem. 2019 May 1;27(9):1776-1788. doi: 10.1016/j.bmc.2019.03.019. Epub 2019 Mar 8.

PMID:
30898435
5.

Rapid Microbial Identification and Antibiotic Resistance Detection by Mass Spectrometric Analysis of Membrane Lipids.

Liang T, Leung LM, Opene B, Fondrie WE, Lee YI, Chandler CE, Yoon SH, Doi Y, Ernst RK, Goodlett DR.

Anal Chem. 2019 Jan 15;91(2):1286-1294. doi: 10.1021/acs.analchem.8b02611. Epub 2019 Jan 4.

PMID:
30571097
6.

A Prospective Study of Acinetobacter baumannii Complex Isolates and Colistin Susceptibility Monitoring by Mass Spectrometry of Microbial Membrane Glycolipids.

Leung LM, McElheny CL, Gardner FM, Chandler CE, Bowler SL, Mettus RT, Spychala CN, Fowler EL, Opene BNA, Myers RA, Goodlett DR, Doi Y, Ernst RK.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01100-18. doi: 10.1128/JCM.01100-18. Print 2019 Mar.

PMID:
30567747
7.

Genomic and Phenotypic Diversity among Ten Laboratory Isolates of Pseudomonas aeruginosa PAO1.

Chandler CE, Horspool AM, Hill PJ, Wozniak DJ, Schertzer JW, Rasko DA, Ernst RK.

J Bacteriol. 2019 Feb 11;201(5). pii: e00595-18. doi: 10.1128/JB.00595-18. Print 2019 Mar 1.

8.

Rickettsia Lipid A Biosynthesis Utilizes the Late Acyltransferase LpxJ for Secondary Fatty Acid Addition.

Guillotte ML, Gillespie JJ, Chandler CE, Rahman MS, Ernst RK, Azad AF.

J Bacteriol. 2018 Sep 10;200(19). pii: e00334-18. doi: 10.1128/JB.00334-18. Print 2018 Oct 1.

9.

In Vivo Intradermal Delivery of Bacteria by Using Microneedle Arrays.

Chandler CE, Harberts EM, Laemmermann T, Zeng Q, Opene BN, Germain RN, Jewell CM, Scott AJ, Ernst RK.

Infect Immun. 2018 Aug 22;86(9). pii: e00406-18. doi: 10.1128/IAI.00406-18. Print 2018 Sep.

10.

Probing the sRNA regulatory landscape of P. aeruginosa: post-transcriptional control of determinants of pathogenicity and antibiotic susceptibility.

Zhang YF, Han K, Chandler CE, Tjaden B, Ernst RK, Lory S.

Mol Microbiol. 2017 Dec;106(6):919-937. doi: 10.1111/mmi.13857. Epub 2017 Nov 2.

11.

Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria.

Barker WT, Martin SE, Chandler CE, Nguyen TV, Harris TL, Goodell C, Melander RJ, Doi Y, Ernst RK, Melander C.

Bioorg Med Chem. 2017 Oct 15;25(20):5749-5753. doi: 10.1016/j.bmc.2017.08.055. Epub 2017 Sep 9.

12.

Bacterial lipids: powerful modifiers of the innate immune response.

Chandler CE, Ernst RK.

F1000Res. 2017 Aug 7;6. pii: F1000 Faculty Rev-1334. doi: 10.12688/f1000research.11388.1. eCollection 2017. Review.

13.

Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens.

Liu YY, Chandler CE, Leung LM, McElheny CL, Mettus RT, Shanks RMQ, Liu JH, Goodlett DR, Ernst RK, Doi Y.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00580-17. doi: 10.1128/AAC.00580-17. Print 2017 Jun.

14.

Rapid lipid a structure determination via surface acoustic wave nebulization and hierarchical tandem mass spectrometry algorithm.

Yoon SH, Liang T, Schneider T, Oyler BL, Chandler CE, Ernst RK, Yen GS, Huang Y, Nilsson E, Goodlett DR.

Rapid Commun Mass Spectrom. 2016 Dec 15;30(23):2555-2560. doi: 10.1002/rcm.7728.

PMID:
27582344
15.

Modification of the 1-Phosphate Group during Biosynthesis of Capnocytophaga canimorsus Lipid A.

Renzi F, Zähringer U, Chandler CE, Ernst RK, Cornelis GR, Ittig SJ.

Infect Immun. 2015 Dec 7;84(2):550-61. doi: 10.1128/IAI.01006-15. Print 2016 Feb.

16.

CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.

Chandler CE, Wilder DE, Pettini JL, Savoy YE, Petras SF, Chang G, Vincent J, Harwood HJ Jr.

J Lipid Res. 2003 Oct;44(10):1887-901. Epub 2003 Jul 1.

17.

Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action.

Morehouse LA, Bangerter FW, DeNinno MP, Inskeep PB, McCarthy PA, Pettini JL, Savoy YE, Sugarman ED, Wilkins RW, Wilson TC, Woody HA, Zaccaro LM, Chandler CE.

J Lipid Res. 1999 Mar;40(3):464-74.

18.

Steroidal glycoside cholesterol absorption inhibitors.

DeNinno MP, McCarthy PA, Duplantier KC, Eller C, Etienne JB, Zawistoski MP, Bangerter FW, Chandler CE, Morehouse LA, Sugarman ED, Wilkins RW, Woody HA, Zaccaro LM.

J Med Chem. 1997 Aug 1;40(16):2547-54.

PMID:
9258361
19.

11-Ketotigogenin cellobioside (pamaqueside): a potent cholesterol absorption inhibitor in the hamster.

McCarthy PA, DeNinno MP, Morehouse LA, Chandler CE, Bangerter FW, Wilson TC, Urban FJ, Walinsky SW, Cosgrove PG, Duplantier K, Etienne JB, Fowler MA, Lambert JF, O'Donnell JP, Pezzullo SL, Watson HA Jr, Wilkins RW, Zaccaro LM, Zawistoski MP.

J Med Chem. 1996 May 10;39(10):1935-7. No abstract available.

PMID:
8642548
20.

Transepithelial transport of cholyltaurine by Caco-2 cell monolayers is sodium dependent.

Chandler CE, Zaccaro LM, Moberly JB.

Am J Physiol. 1993 Jun;264(6 Pt 1):G1118-25.

PMID:
8333540
21.

Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside).

Harwood HJ Jr, Chandler CE, Pellarin LD, Bangerter FW, Wilkins RW, Long CA, Cosgrove PG, Malinow MR, Marzetta CA, Pettini JL, et al.

J Lipid Res. 1993 Mar;34(3):377-95.

22.

Efficacy, tissue distribution and biliary excretion of methyl (3R*,5S*)-(E)-3,5-dihydroxy-9,9-diphenyl-6,8-nonadienoate (CP-83101), a hepatoselective inhibitor of HMG-CoA reductase activity in the rat.

Harwood HJ Jr, Silva M, Chandler CE, Mikolay L, Pellarin LD, Barbacci-Tobin E, Wint LT, McCarthy PA.

Biochem Pharmacol. 1990 Sep 15;40(6):1281-93.

PMID:
2403382
23.

Enucleation of the rat pheochromocytoma clonal cell line, PC12: effect on neurite outgrowth.

Nichols RA, Chandler CE, Shooter EM.

J Cell Physiol. 1989 Nov;141(2):301-9.

PMID:
2808539
24.

Studies of aldose reductase using neuronal cell culture and ligated rat sciatic nerve.

Chandler CE, Miller LJ.

Metabolism. 1986 Apr;35(4 Suppl 1):71-7.

PMID:
3083210
25.

Nerve growth factor does not activate Na+/H+ exchange in PC12 pheochromocytoma cells.

Chandler CE, Cragoe EJ Jr, Glaser L.

J Cell Physiol. 1985 Dec;125(3):367-78.

PMID:
2415539
27.

A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells.

Chandler CE, Parsons LM, Hosang M, Shooter EM.

J Biol Chem. 1984 Jun 10;259(11):6882-9.

28.

Supplemental Content

Loading ...
Support Center